Mydecine Announces Change of Auditor
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) has appointed MNP LLP as its new auditor, replacing SHIM & Associates LLP. The company has filed a Notice of Change of Auditor on SEDAR. This change marks a shift in the company's financial oversight and aligns with its ongoing commitment to transparency and accountability in financial reporting. Stakeholders are encouraged to monitor future performance closely, as this transition may influence investor confidence and regulatory compliance.
- Appointment of MNP LLP may enhance financial oversight and reporting transparency.
- None.
Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), announces that the board of directors of the Company has appointed MNP LLP, Chartered Professional Accountants as the Company’s new auditor, replacing SHIM & Associates LLP (“SHIM”), Chartered Professional Accountant.
The Company has filed a Notice of Change of Auditor in respect of this change under its profile on SEDAR at www.sedar.com.
For further information about Mydecine Innovations Group, Inc., please visit the Company’s profile on SEDAR at www.sedar.com or visit the Company’s website at www.mydecine.com.
This news release contains forward-looking information within the meaning of Canadian securities laws regarding the Company and its business, which relate to future events or future performance and reflect management’s current expectations and assumptions, and which may include, but are not limited to, statements with respect to the completion of the bought deal offering by the Company. Often but not always, forward-looking information can be identified by the use of words such as “expect”, “intends”, “anticipated”, “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would” or “will” be taken, occur or be achieved. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. This news release does not constitute an offer of securities for sale in the United States.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210315005860/en/
FAQ
What recent change occurred at Mydecine Innovations Group regarding auditors?
Where can I find Mydecine Innovations Group's Notice of Change of Auditor?
What is the stock symbol for Mydecine Innovations Group?
How might the auditor change impact Mydecine Innovations Group's stock performance?
